Adalvo acknowledges and participates in World IP Day 2024, joining the global community in celebrating innovation and creativity in intellectual property (IP). This year's theme, "๐๐ ๐๐ง๐ ๐ญ๐ก๐ ๐๐๐๐ฌ: ๐๐ฎ๐ข๐ฅ๐๐ข๐ง๐ ๐จ๐ฎ๐ซ ๐๐จ๐ฆ๐ฆ๐จ๐ง ๐๐ฎ๐ญ๐ฎ๐ซ๐ ๐ฐ๐ข๐ญ๐ก ๐ข๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐จ๐ง ๐๐ง๐ ๐๐ซ๐๐๐ญ๐ข๐ฏ๐ข๐ญ๐ฒ," aligns with our declared purpose of making a difference for patients around the world.
Aligning with Sustainable Development Goal 3 (SDG 3) of the 2030 Agenda for Sustainable Development, which aims to ensure healthy lives and promote well-being for all ages, Adalvo recognizes the role of being resourceful and creative in addressing healthcare challenges. ย
Adalvo's portfolio reflects this commitment, with a range of value-added medicines such as improved formulations like Pregabalin XR and Lisdexamfetamine oral solution, as well as combinations such as Mirabegron + Solifenacin and ย Ambrisentan + Tadalafil. These advancements not only enhance accessibility and affordability but also improve patient adherence, supporting better health outcomes.ย
As we mark World IP Day 2024, Adalvo reaffirms its dedication to advancing global health through intellectual property and high-quality differentiated solutions.ย ย
At Adalvo, there are no half-measures - we are always on target. When your mission is to surpass your competitors, you need a dedicated team driving your vision forward.ย
Partner with us now!ย